Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-480,000
Closed -$26.3M 1806
2022
Q2
$26.3M Hold
480,000
0.09% 138
2022
Q1
$26.2M Buy
+480,000
New +$26.1M 0.08% 153
2021
Q3
Sell
-320,000
Closed -$16M 2077
2021
Q2
$16M Buy
+320,000
New +$15.4M 0.04% 253
2015
Q1
Sell
-160,000
Closed -$8.54M 1974
2014
Q4
$8.54M Hold
160,000
0.02% 412
2014
Q3
$9.21M Buy
+160,000
New +$9.81M 0.03% 463

Other funds holding GSK

Nomura Holdings's GSK Position: Q3 2024 in Review

Nomura Holdings sold out of GSK (GSK) in Q3 2024, closing a stake of 25,124 shares — an estimated $967K sold.

Nomura Holdings first reported a position in GSK in Q2 2013 and held it in 26 quarters. The position peaked at $193M in Q4 2021. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Nomura Holdings reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Nomura Holdings sold 25,124 GSK shares in Q3 2024, an estimated $967K.
  • Nomura Holdings first reported a position in GSK in Q2 2013 and held it in 26 quarters.
  • Nomura Holdings's GSK position peaked at $193M in Q4 2021.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Nomura Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.